Thibaud is a chemical engineer with a PhD in biotechnology and has more than 25 years of experience in the biopharmaceutical industry. He has held various positions of growing management responsibilities in Technical Development and Technical Operations for Drug Substance and Drug Product, in vaccine and biopharmaceutical companies. He has lead the technical development and contributed to the commercial launch of the very first biosimilars in Europe and USA. He has extensive experience in Operational Excellence, Lean leadership and digital transformation. At Lonza, Thibaud leads 7 sites in charge of the technical development, clinical manufacturing and commercial manufacturing of biologics using mammalian, microbial, drug-conjugation and mRNA technologies.

Nik has been with Lonza for almost 30 years. Educated in science and with a degree in Business Administration, Nik has had various operational and commercial roles at Lonza. He began in cell culture operations in the Slough UK facility then transferred to Portsmouth NH USA facility to start up operations and support the expansion of large scale production suites, ultimately leading the Cell Culture Operations team across the site. In 2007 Nik transferred to the Tuas, Singapore site to head manufacturing operations at both the 20,000L scale facilities that Lonza built. Since 2012 Nik has been in the Lonza commercial team beginning in the sales team as a global account manager and then in commercial development for mammalian, microbial and bioconjugates technologies. Nik is currently Head of Commercial Development for the Market Supply Portfolio of customers within Lonza’s mammalian network.